Robuta

Sponsor of the Day: Jerkmate
https://www.webmd.com/drugs/updates/awiqli-once-weekly-long-acting-basal-insulin-for-adults-with-type-2-diabetes Awiqli: FDA Approves First and Only Once-Weekly Long-Acting Basal Insulin for Adults With Type 2... The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers convenient weekly dosing compared... fda approves firstlong actingbasal insulintype 2weekly https://superpower-health.webflow.io/calculator/basal-insulin Basal Insulin Calculator for Type 1 & Type 2 Diabetes type 1 2basal insulincalculatordiabetes https://www.healio.com/news/endocrinology/20260327/fda-approves-onceweekly-basal-insulin-for-adults-with-type-2-diabetes FDA approves once-weekly basal insulin for type 2 diabetes Mar 27, 2026 - The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal insulin, Novo Nordisk announced.... type 2 diabetesfda approvesweekly basalinsulin https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-awiqli-the-first-and-only-once-weekly-basal-insulin-treatment-for-adults-with-type-2-diabetes-302726839.html FDA approves Novo Nordisk's Awiqli®, the first and only once-weekly basal insulin treatment for... Mar 26, 2026 - /PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae) injection 700... fda approvesnovo nordiskweekly basalinsulin treatmentfirst https://abbott.mediaroom.com/2026-03-12-Landmark-study-shows-Libre-technology-helps-people-with-Type-2-diabetes-on-basal-insulin-improve-glucose-management Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve... landmark study showstechnology helps peopletype 2 diabetesbasal insulinlibre